Immediate Impact
8 from Science/Nature 64 standout
Citing Papers
Metabolic reprogramming in the tumor microenvironment of liver cancer
2024 Standout
Natural killer cell therapies
2024 StandoutNature
Works of Manik Amin being referenced
Safety and efficacy of the anti-CD73 monoclonal antibody (mAb) oleclumab ± durvalumab in patients (pts) with advanced colorectal cancer (CRC), pancreatic ductal adenocarcinoma (PDAC), or EGFR-mutant non-small cell lung cancer (EGFRm NSCLC).
2021
Safety, efficacy and pharmacodynamics (PD) of MEDI9447 (oleclumab) alone or in combination with durvalumab in advanced colorectal cancer (CRC) or pancreatic cancer (panc).
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Manik Amin | 343 | 160 | 62 | 123 | 53 | 566 | |
| Johannes Doescher | 239 | 141 | 36 | 106 | 44 | 464 | |
| Annika Ålgars | 383 | 118 | 28 | 146 | 34 | 635 | |
| Yu Fujiwara | 280 | 64 | 39 | 90 | 53 | 481 | |
| Charlene Mantia | 262 | 122 | 75 | 122 | 50 | 608 | |
| Maarit Ahtiainen | 340 | 76 | 39 | 162 | 43 | 592 | |
| Seisho Sakai | 185 | 102 | 64 | 135 | 44 | 544 | |
| Ken Kojo | 161 | 122 | 61 | 200 | 28 | 468 | |
| Dariusz Waniczek | 243 | 109 | 62 | 206 | 56 | 568 | |
| Nagla Abdel Karim | 269 | 83 | 172 | 185 | 60 | 599 | |
| Feng Wang | 230 | 94 | 68 | 262 | 51 | 572 |
All Works
Login with ORCID to disown or claim papers
Loading papers...